These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23436070)

  • 1. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients.
    Varrone A; Mattsson P; Forsberg A; Takano A; Nag S; Gulyás B; Borg J; Boellaard R; Al-Tawil N; Eriksdotter M; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Lammertsma AA; Halldin C
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):921-31. PubMed ID: 23436070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
    Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
    Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
    Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C
    EJNMMI Res; 2013 Apr; 3(1):30. PubMed ID: 23618062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide.
    James ML; Belichenko NP; Nguyen TV; Andrews LE; Ding Z; Liu H; Bodapati D; Arksey N; Shen B; Cheng Z; Wyss-Coray T; Gambhir SS; Longo FM; Chin FT
    J Nucl Med; 2015 Feb; 56(2):311-6. PubMed ID: 25613536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphic plot analysis for estimating binding potential of translocator protein (TSPO) in positron emission tomography studies with [¹⁸F]FEDAA1106.
    Ikoma Y; Takano A; Varrone A; Halldin C
    Neuroimage; 2013 Apr; 69():78-86. PubMed ID: 23247191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of the translocator protein positron emission tomography ligand [
    Feeney C; Scott G; Raffel J; Roberts S; Coello C; Jolly A; Searle G; Goldstone AP; Brooks DJ; Nicholas RS; Trigg W; Gunn RN; Sharp DJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.
    Guo Q; Colasanti A; Owen DR; Onega M; Kamalakaran A; Bennacef I; Matthews PM; Rabiner EA; Turkheimer FE; Gunn RN
    J Nucl Med; 2013 Nov; 54(11):1915-23. PubMed ID: 24071511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of a novel
    Yan X; Siméon FG; Liow JS; Morse CL; Montero Santamaria JA; Jenkins M; Manly LS; Van Buskirk M; Zoghbi SS; Pike VW; Innis RB; Zanotti-Fregonara P
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2962-2970. PubMed ID: 37249618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.
    Takano A; Gulyás B; Varrone A; Karlsson P; Sjoholm N; Larsson S; Jonsson C; Odh R; Sparks R; Al Tawil N; Hoffmann A; Zimmermann T; Thiele A; Halldin C
    Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2058-65. PubMed ID: 21732107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.
    Fan Z; Calsolaro V; Atkinson RA; Femminella GD; Waldman A; Buckley C; Trigg W; Brooks DJ; Hinz R; Edison P
    J Nucl Med; 2016 Nov; 57(11):1753-1759. PubMed ID: 27261523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic modeling and non-invasive approach for translocator protein quantification with
    Yasuno F; Kimura Y; Ogata A; Ikenuma H; Abe J; Minami H; Nihashi T; Yokoi K; Hattori S; Shimoda N; Ichise M; Sakurai T; Ito K; Kato T
    Nucl Med Biol; 2022; 108-109():76-84. PubMed ID: 35349913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Evaluation of 6 Analogs of
    Lee JH; Siméon FG; Liow JS; Morse CL; Gladding RL; Santamaria JAM; Henter ID; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2022 Aug; 63(8):1252-1258. PubMed ID: 35027372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
    Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
    Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.
    Ikawa M; Lohith TG; Shrestha S; Telu S; Zoghbi SS; Castellano S; Taliani S; Da Settimo F; Fujita M; Pike VW; Innis RB;
    J Nucl Med; 2017 Feb; 58(2):320-325. PubMed ID: 27856631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.
    Lavisse S; Guillermier M; Hérard AS; Petit F; Delahaye M; Van Camp N; Ben Haim L; Lebon V; Remy P; Dollé F; Delzescaux T; Bonvento G; Hantraye P; Escartin C
    J Neurosci; 2012 Aug; 32(32):10809-18. PubMed ID: 22875916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.